Search

everythinglearnresearchcommunity

for

Search:↓

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

Large prostate patients more likely to have hair loss.

Finasteride works better than Permixon in reducing dihydrotestosterone levels.

5-alpha reductase deficiency leads to male sexual development issues and treatments like finasteride help with prostate enlargement and hair loss.

Quick, selective detection of tadalafil and finasteride in human plasma developed.

Finasteride lowers DHT levels and raises testosterone in a dose-dependent way.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

The body's change of testosterone into DHT is not necessary for testosterone's muscle and sexual effects.

The document discusses new insights into how hormones affect male sexual health and related conditions.

Finasteride may decrease semen quality but not harm sperm production, and stopping the drug can improve semen quality; hyperprolactinemia can cause infertility but is treatable with medication.

Finasteride and dutasteride have little effect on Type 2 Diabetes risk.

Correcting vitamin D and progesterone deficiencies can significantly improve hair loss, acne, and BPH symptoms.

Dutasteride is a safe and effective treatment for hair loss.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Finasteride may help reduce inappropriate sexual behaviors in dementia patients with prostate issues.

Larger prostate size, longer surgery, and smoking increase risks, while finasteride and experienced surgeons reduce them during prostate surgery.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Ganoderma lucidum may help treat enlarged prostate in rats.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

Finding new uses for existing drugs is promising and can lead to safer, more effective medicines.

Men with depression and marijuana usage are more likely to be treated for lower urinary tract symptoms/benign prostatic hyperplasia.

BPH medications may increase the risk of self-harm and depression, especially in the first 18 months.

Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.